Low-Molecular-Weight Heparin in Acute Coronary Syndromes

Publisher： Karger

E-ISSN： 1424-0556|4|3|111-118

ISSN： 1422-9528

Source： Heart Drug, Vol.4, Iss.3, 2004-08, pp. : 111-118

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evidence for the Benefits of the Low-Molecular-Weight Heparin Dalteparin in ‘High-Risk’ Patients with Acute Coronary Syndromes

By  

Heart Drug, Vol. 4, Iss. 3, 2004-08 ,pp. : 157-163

Karger

Access to resources Recommend Favorite

Use of Unfractionated Heparin and a Low-Molecular-Weight Heparin following Thrombolytic Therapy for Acute ST-Segment Elevation Myocardial Infarction

By Wang Xu-Kai   Zhang Ye   Yang Cheng-Ming   Wang Yan   Liu Guang-Yao  

Clinical Drug Investigation, Vol. 26, Iss. 6, 2006-01 ,pp. : 341-349

Adis International

Access to resources Recommend Favorite

Pellets for oral administration of low-molecular-weight heparin

By Scala-Bertola Julien   Gajdziok Jan   Rabišková Miloslava   Bonneaux François   Lecompte Thomas   Sapin Anne   Maincent Philippe  

Drug Development and Industrial Pharmacy, Vol. 35, Iss. 12, 2009-12 ,pp. : 1503-1510

Informa Healthcare

Access to resources Recommend Favorite

Low molecular weight heparin in acute stroke

By Bath P.M.  

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 8, 1998-08 ,pp. : 1323-1330

Informa Healthcare

Access to resources Recommend Favorite

Costs and Cost Effectiveness of Low Molecular Weight Heparins and Platelet Glycoprotein IIb/IIIa Inhibitors: In the Management of Acute Coronary Syndromes

By Bosanquet N.  

PharmacoEconomics, Vol. 21, Iss. 16, 2003-01 ,pp. : 1135-1152

Adis International

Access to resources Recommend Favorite